Single cell RNA sequencing (scRNAseq) technique is becoming increasingly popular for unbiased and high-resolutional transcriptome analysis of heterogeneous cell populations.
sequencing, and unwanted biological confounders such as cell cycle status. These hidden confounding factors can cause systematic bias, are notoriously difficult control for, and are the focus of the present study.
To mitigate the influence of hidden confounding factors, existing statistical methods in scRNAseq studies take advantage of a set of control genes [24, 25] . Specifically, these methods divide genes into two sets: a control set of genes that are used to infer the confounding factors and a target set of genes that are of primary interest. The confounding factors inferred from the control set are used to remove unwanted variation in the target genes for subsequent downstream analysis. For example, most scRNAseq studies add ERCC spike-in controls during the PCR amplification and sequencing steps. The spike-in controls can be used to capture the hidden confounding technical noise associated with the experimental procedures for normalizing genes of primary interest [26] . Similarly, most scRNAseq studies include a set of control genes that are known to have varying expression levels across cell cycles. These cell cycle genes can be used to capture the unmeasured cell cycle status of each cell, which is further used to normalize target genes [24] . Various statistical methods can be used to infer the confounding effects from control genes. For example, principal component analysis (PCA) or factor models extract the principal components or factors from the set of control genes as surrogates for the confounding factors [25, [27] [28] [29] . Linear mixed models (LMMs) or single cell latent variable models (scLVM) construct a sample relatedness matrix based on the control genes to capture the influence of the confounding factors [24, 26, 30] . Other methods fit smooth curves to interpolate and estimate the overall contribution of the technical variation from the control genes [31] .
Although straightforward, these statistical methods overlook one important fact --that the hidden confounding factors not only influence the control genes but also the target genes -i.e. the exact reason that we need to remove such unwanted variation in the first place. Because the confounding factors influence both control and target genes, using control genes alone to infer the confounding factors can be suboptimal as it fails to use the information from target genes. Thus, existing statistical methods do not make full use of the information contained in the data to remove the unwanted variation that can influence downstream analysis.
To infer latent confounding factors from scRNAseq studies and remove unwanted variation, we develop a novel statistical method, which we refer to as scPLS. scPLS is based on the partial least squares regression models and incorporates both control and target genes to infer hidden confounding effects. In addition, our method can model other systematic biological variation and heterogeneity, which are often observed in the target genes. By incorporating such
Results

Method Overview
We consider dividing genes into two sets: a control set that contains control genes and a target set that contains genes of primary interest. The control genes are selected based on the purpose of the analysis. For example, the control set would contain ERCC spike-ins if we want to remove technical confounding factors, and would contain cell cycle genes if we want to remove cell cycle effects. We use the partial least squares (PLS) regression to jointly model both control and target genes:
where for i'th individual cell, ! is a q-vector of expression level for q control genes; ! is a pvector of expression level for p target genes; ! is ! -vector of unknown confounding factors that affect both control and target genes; the confounding effects are represented by the q by ! loading matrix ! for the control genes and the p by ! loading matrix ! for the target genes;
! is a ! -vector of unknown factors in the target genes representing structured variation (see below); ! is a p by ! loading matrix; !" is an q-vector of idiosyncratic error with covariance
is an p-vector of idiosyncratic error with covariance
We have assumed that the expression levels of each gene have been centered to have mean zero, allowing us to ignore the intercept.
Our model includes two types of unknown latent factors. The first set of factors, ! , represents the unknown confounding factors that affect both control and target genes. The effects of ! on the control and target genes are captured in the loading matrices ! and ! , respectively. We call ! the confounding factors throughout the text, and we aim to remove the factor effects ! ! from the target genes. The second set of factors, ! , aims to capture a low dimensional structure of the expression level of p target genes. The factors ! are sometimes referred to as gene signatures, representing intermediate factors that coordinately regulate a set of genes in biological processes and/or specific experimental perturbations. These factors can be interpreted as cell subtypes, treatment status, transcription factors or regulators of biological pathways in different studies [32] [33] [34] [35] [36] . Although ! could be of direct biological interest in many data sets, we do not explicitly examine the inferred ! here. Rather, we view modeling ! in the target genes as a way to better capture the complex variance structure, and to facilitate precise estimation of the confounding factors ! . For simplicity, we call ! the biological factors throughout the text, though we note that ! could well represent non-biological processes such as treatment or environmental effects. Thus, the expression levels of the control genes can be described by a linear combination of the confounding factors ! and residual errors; the expression levels of the target genes can be described by a linear combination of the confounding factors ! , the biological factors ! and residual errors. For both types of confounding factors, we are interested in inferring the factor effects ! ! and ! ! rather than the individual factors ! and ! . Therefore, unlike in standard factor models, we are not concerned with the identifiability of the factors. Figure 1 shows an illustration of scPLS.
We develop an expectation-maximization (EM) algorithm to estimate the parameters in the latent factor model. Our algorithm treats the latent factors as missing data and uses an iterative procedure to compute the expectation of factors in the E-step and update the factor loading matrices in the M-step (details in the Supplementary Text). This naïve EM algorithm, however, is computationally expensive, and scales quadratically with the number of genes and linearly with the number of samples. To improve the computational speed, we develop a new EM-in-chunks algorithm. Our algorithm is based on the observation that the expression levels of the target genes are determined by the same set of underlying factors and that these factors can be estimated accurately even with a small subset set of target genes. This allows us to randomly divide target genes into dozens of chunks, compute the expectation of the factors in each chunk separately in the E-step, and then average these expectations across chunks. With the averaged expectations, we then update the factor loading matrices in the M-step. Thus, our new algorithm modifies the E-step in the naïve algorithm and is c times faster than the naïve one, where c is the number of chunks. Simulations show that our EM-in-chunks algorithm yields comparable results to the naïve EM algorithm with respect to estimation errors, but can be an order of magnitude faster (Table S1 ). To determine the number of confounding factors and biological factors, we evaluate the likelihood on a grid of ! and ! values and choose the optimal combination that minimizes the Bayesian information criterion (BIC). After parameter estimation, we use the residuals ! = ! − ! ! as the de-noised values for subsequent analysis.
Notice that the residuals are only free of confounding effects ! ! but still contain the biological factor effects ! ! .
Simulations
Our method improves upon previous methods in two important ways. First, it explicitly models the effects of confounding factors on both control and target genes. Second, it accounts for a low dimensional structure in the expression levels of target genes with the biological factors ! .
Both features are expected to improve the normalization of target genes. To illustrate the benefits of these two features, we perform a simulation study. Details of the simulations are described in Methods. Briefly, we simulate gene expression levels for 50 control genes and 1,000 target genes for 200 cells. These 200 cells come from two equal-sized groups, representing two treatment conditions or two sub-cell types. Among the 1,000 target genes, only 100 of them are differentially expressed (DE) between the two groups and thus represent the signature of the two groups. The effect sizes of the DE genes are simulated from a normal distribution, and we scale the effects further so that the group label explains a fixed percentage of phenotypic variation (PVE) in expression levels in the DE genes (ranging from 1% to 20%, with 1% intervals). In addition to the group effects, we simulate the confounding factors ! to explain 10% PVE in either the control or the target genes, the biological factors ! to explain either 0% (i.e. no effect) or 30% PVE of the target genes, and the residual errors to explain the rest of PVE. To make the simulations realistic, these PVE values are based on real data sets.
For the confounding factors ! , we consider two scenarios: a simple scenario where ! is not correlated with the group label, and a complicated but perhaps more realistic scenario where ! is correlated with the group label.
We then compare our method to two commonly used methods --the PCA method and the LMM method -that use control genes to infer confounding effects. To illustrate the benefit of the biological factors ! , we also compare our full model to a reduced model that does not contain the biological factors. Our goal on the simulated data is twofold: we want to identify these differentially expressed genes and to classify the 200 cells into two groups. Therefore, we compare the performance of various methods based on two criteria: the power to identify the DE genes and the power to classify cells into two groups. We permute group labels to construct an empirical null and compare methods based on either power given a certain false discovery rate (FDR) for identifying DE genes or accuracy for classification.
Because our method infers the confounding factors ! using information from both control and target genes, it can estimate the confounding effects more precisely than other methods and thus result in better gene expression estimates in the target set ( Figure S1 ). For instance, the correlation between the true and estimated confounding effects is on average 0.84 for scPLS, 0.81 for PCA, and 0.61 for LMM (p-value < 10 -16 for scPLS vs PCA and p-value = 0.015 for scPLS vs LMM). Due to the better normalization of expression levels, our method is more powerful than both PCA and LMM in identifying DE genes (Figures 2a and S2 ).
Specifically, when PVE=10%, scPLS achieves an average power of 58.4% for detecting DE genes, while LMM and PCA achieve an average power of 38.5% and 42.2%, respectively; when PVE=20%, scPLS achieves an average power of 71.4% for detecting DE genes, while LMM and PCA achieve an average power of 55.7% and 58.9%, respectively. The improvement of scPLS over other methods is especially significant in the scenario where the confounding factors are correlated with the group label, as the benefits of using the target genes in addition to the control genes become more important (Figure 2a vs Figure S2 ). Interestingly, for detecting DE genes, when the group effect size is small, methods that remove technical confounding factors may perform even worse than uncorrected data, presumably because of model over-fitting (Figure 2a) . However, while PCA and LMM outperform the uncorrected data only when the group effect size is above PVE=10%, scPLS outperforms the uncorrected data for a small PVE of 5%, suggesting that scPLS is more robust to model over-fitting.
One important benefit of scPLS, compared with others, is that it is less sensitive to the number of control genes used in the analysis. Because scPLS does not completely rely on information from the control genes, it achieves reasonably good performance even if we only use a much smaller subset of control genes. In contrast, the performance of other methods compromise more quickly with a reduced number of control genes ( Figure 2b (Figure 2c ). To further quantify the classification performance, we apply the support vector machine (SVM) to classify the cells. We perform a five-fold cross-validation, training SVM with 80% of the samples and evaluating the prediction accuracy with the rest of the samples. As expected, scPLS outperforms the other two methods ( Figure 2d ). When PVE is 10%, scPLS achieves an average accuracy of 98% across 10 replicates, while LMM and PCA only achieve 84.3%. When PVE is 20%, scPLS achieves 99%, while LMM and PCA achieve 91.5% and 88.5%, respectively. Figure S3b ). As it is often unknown whether a low-rank structural variation exists in a real data set, our simulation suggests that we can always include the biological factors ! in the model.
Real Data Applications
Next, we illustrate the benefits of our method in three real data sets. The first dataset is used to demonstrate the effectiveness of scPLS in removing the technical confounding effects by using ERCC spike-ins. Removing technical confounding effects is a common and important task in transcriptome analysis. The second dataset is used to demonstrate the effectiveness of scPLS in removing cell cycle effects by using a known set of cell cycle genes. Removing cell cycle effects can reveal gene expression heterogeneity that is otherwise obscured. Finally, with the third dataset, we demonstrate the effectiveness of scPLS in removing both technical confounding effects and cell cycle effects.
Removing Technical Confounding Factors
The first dataset consists of 251 samples of mouse embryonic stem cells (mESCs). The cells were cultured in two different media: two-inhibitor (2i) medium or serum medium. The cells in each medium were collected in two different ways: either as single cell samples subject to scRNAseq or as pooled samples subject to pooled RNAseq. Therefore, the samples can be divided into four different categories based on the medium type and collection type. We use ERCC spike-ins as controls and all other genes as the target. In this data, scPLS infers ! = 1 confounding factors and ! = 1 biological factors. In the target genes, the confounding factors and biological factors explain a median of 16.1% and 33.9% of gene expression variance, respectively. The PVE by the technical factors are higher in highly variable genes. For example, in the top 500 genes with the largest variance, the two sets of factors explain a median of 18.6%
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We first visualize the uncorrected data and data corrected by scPLS with heatmap ( Figure 3b ). Before correction, there is a large variation in gene expression levels across samples in each category. However, this large variance is due to technical confounding. After correction, the variability of samples within each category is considerably reduced.
We next compare the efficacy of scPLS with other methods in removing technical confounding factors. Here, in addition to LMM and PCA, we also compare with RUV, a method specifically designed to remove technical confounding factors by using control genes [25] .
Because the data consists of four sample categories, we compare the performance of methods based on whether the corrected data can better reveal four distinct groups. In particular, if a method effectively removes confounding effects, the top PCs from the corrected data can be used to better distinguish the four categories. Thus, we extract the top PCs from both corrected data and uncorrected data. For each PC, we compute a ratio of within-category variance and the total-variance. A small ratio suggests that this particular PC can be used to distinguish the four categories. We then contrast the ratio from the k'th PC in the corrected data with the ratio from the k'th PC in the uncorrected data, and compute the reduction in ratio as a measurement of performance; a large reduction suggests better performance. As expected, data corrected by scPLS achieves the largest reduction in ratio, suggesting that scPLS outperforms the other methods ( Figure 3c ). For example, the within-cluster variance ratio for the first PC is reduced 30% by scPLS. In contrast, the decrease in the ratio for the first PC by PCA, LMM and RUV is only 25.1%, 24.5% and 23.6%, respectively. The trend is apparent for all top PCs. For example, for the 10'th PCs, the ratio is reduced 13.4% by scPLS. In contrast, the ratio reduced by PCA, LMM and RUV are only 10.4%, 9.9% and 9.3%, respectively. The results suggest that scPLS performs better than the alternatives and can better reveal distinct sample categories in the data.
Removing Cell Cycle Effects
The second dataset measured the expression level of 301 single cells from either the utricular or the cochlear sensory epithelia in the inner ear of newborn mice [37] . The cells from each of the two tissues (i.e. utricle and cochlea) can be classified into three cell types (the hair cells, or HCs; the transitional epithelial cells, or TECs; and supporting cells, or SCs), resulting in a total of six distinct cell types. We 282 known cell cycle genes as controls and all other genes as targets. scPLS infers ! = 2 confounding factors of cell cycle and ! = 2 biological factors. The cell cycle confounding factors and biological factors explain a median of 11.9% and 1.4% of . CC-BY-NC-ND 4.0 International license peer-reviewed) is the author/funder. It is made available under a The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/045070 doi: bioRxiv preprint first posted online Mar. 22, 2016; gene expression variance, respectively. The PVE by the latent factors are higher in highly variable genes. For example, both factors explain a median of 18.0% and 2.4% of gene expression variance, respectively, in the top 500 genes with the largest variance. The PVE by the confounding and biological factors can be as high as 91.5% and 73.4% (Figure 4a ).
We first perform a PC analysis on the uncorrected data and the scPLS corrected data. In the uncorrected data, PC1 and PC2 separated cells into two clusters (Figure 4b ). However, these two clusters do not represent tissue groups. Instead, one cluster consists largely of HCs from the two tissues while the other cluster consists of the other four cell types. PC1 and PC3 separate cells into the expected two tissue groups. On the other hand, PC1 and PC2 of scPLS corrected data directly cluster cells according to the cell type (Figure 4b ). This suggests that PC1 of the uncorrected data may represent cell cycle effects. To directly test this, we extract PCs from the cell cycle genes and denote the first PC as the cell cycle PC (ccPC). We expect this ccPC to represent the majority of the cell cycle effects, as it accounts for 50.1% of variance among the top five PCs of cell cycle genes. In either the uncorrected data or scPLS corrected data, we calculate the correlation of PC1, PC2 and PC3 with ccPC ( Figure 4c ). In the uncorrected data, PC1 is highly corrected with ccPC with a striking correlation of 0.96 (p-value < 10 -16 ). PC2 is also correlated with ccPC but to a much lesser degree, and PC3 is not correlated We then compare the performance of scPLS with other methods in this data. In addition to PCA and LMM, this time, we also include scLVM for comparison. scLVM is specifically designed to remove cell cycle effects [24] . Because we do not know the true cell cycle label here (unlike the following data; see below), we use two different criteria to compare different methods.
Our first criterion is the correlation of PCs with ccPC as described in the paragraph above. All methods are able to reduce the correlation between PC1 and ccPC. For example, ccPC is not highly correlated with PC1 from PCA (r = 0.02), LMM (r= 0.02) or scLVM (r=0.05).
However, among all the methods, PC1 from scPLS corrected data has the smallest correlation with ccPC (r=5.6 x 10 -5; p-value < 1.0 x 10 -16 for scPLS vs PCA, p-value < 1.0 x 10 -16 for scPLS vs LMM, and p-value = 0.001 for scPLS vs scLVM), suggesting that scPLS works best among
all. A similar trend is observed for PC2. However for PC2, both scPLS and scLVM work well and reduce the correlation to near zero.
Our second criterion to compare the methods is based on a subset analysis. For this criterion, we randomly split the cell cycle genes into two sets: one set (150 genes) is used as the control set as usual, but the other set (132 genes) is included in the target gene set and used for validation purpose. We perform four replicates of split. We reason that, if a method works well to remove the cell cycle effects, then the 132 genes in the validation set should be free of cell cycle effects, and thus would no longer be highly correlated with each other or with genes in the control set. In the uncorrected data, the control genes and validating genes are highly positively correlated with each other (Figure 4d ). The standard hierarchical clustering algorithm cannot separate these two sets and genes from the two sets are intermingled in the hierarchical cluster. In contrast, after scPLC correction, the high correlations between the control genes and validating genes are largely gone. The standard hieratical clustering algorithm can easily separate the control genes and the validating genes (Figure 4d significantly different compared to scPLS, suggesting that these methods are also effective in removing cell cycle effects.
In conclusion, based both criteria, scPLS can effectively remove cell cycle effects, and more so than the other methods.
Removing Both Technical Effects and Cell Cycle Effects
Our method can also be used to remove both technical effects and cell cycle effects. We can accomplish this in two steps. First, we use the spike-in genes as the control set and all genes as the target set to jointly infer and remove the technical confounding effects. Then, with the corrected gene expression levels from the first step, we further use the cell cycle genes as the control set and other genes as the target set to estimate and remove the cell cycle effects.
.
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To demonstrate the effectiveness of the two-step approach, we apply our method to a third dataset. This dataset contains the transcriptional profile of 182 embryonic stem cells (ESCs) with pre-determined cell-cycle phases (G1, S and G2M) [24] . We used 92 ERCC spike-ins as the control genes and a set of 9,121 genes selected in the previous study [24] . To remove cell cycle effects, we use 629 annotated cell-cycle genes as controls and other genes as targets.
scPLS infers !! = 1 technical confounding factors, !! = 1 cell cycle confounding factors, and ! = 1 biological factors at the second step. These factors explain a median of 0.4%, 3.1%, and 0.7% of gene expression variance, respectively (Figure 5a) . The PVE by the three components --the confounding, cell cycle factors and biological factors --can be as high as 40.0%, 74.8% and 37%. We visualize the uncorrected data and scPLS corrected data with a PCA plot ( Figure   5b ). In the uncorrected data, there is a clear separation of cells according to cell-cycle stage.
Such separation of cells is not observed in the corrected data, indicating that the cell cycle related expression signature is effectively removed.
We compare the performance of scPLS with the other three methods. Here, both LMM and PCA use the same two-step procedure while scLVM uses the procedure developed earlier [24] . We evaluate the performance based on two different criteria. For the first criterion, we compute for each gene the proportion of expression variance explained by the cell cycle factor.
We denote this quantity as PVEi, which stands for inferred PVE. Because the cell-cycle stage of each cell has been experimentally determined in this data set, we further compute the variance explained by the true cell cycle labels. We denote this quantity as PVEt, which stands for true PVE. For scPLS, PVEi and PVEt are highly correlated (r 2 = 0.77), demonstrating the efficacy of scPLS ( Figure 5c ). Importantly, the correlation is similar whether we use the naïve EM algorithm, or the EM-in-chunks algorithm with either the full control set or with a subset of 300 controls ( Figure S4 ). The correlation between PVEi and PVEt in scPLS is higher than that from scLVM To further validate the efficacy of our approach, we again randomly split the cell cycle genes into two sets: one is used as the controls (300 genes), and the other (329) as a validation .
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The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/045070 doi: bioRxiv preprint first posted online Mar. 22, 2016; set, included in the target set. In the uncorrected data, the control genes and validating genes are highly correlated with each other and intermingled ( Figure S5b) . After scPLC correction, the correlation between the control genes and the validating genes is largely gone and the two set could be easily separated. To quantitatively measure the reduction in correlations, we compute all pair-wise correlations between genes from the controls set and genes from the validation set ( Figure S5a) . scPLS reduces the median correlation among genes from 0.075 to 0.052 (p-value = 0.0001), and reduces the 95% quantile correlation from 0.219 to 0.158 (p-value = 0.0001). As a comparison, PCA and LMM reduce the median correlation among genes to 0.057, and 0.056, both of which are significantly less than scPLS (p-value = 7.0 x 10 -5 , and 5.53 x 10 -5 for scPLS vs PCA, scPLS vs LMM, respectively). scLVM reduces the median correlation among genes to 0.052, which is not significantly different from scPLS (p-value =0.483).
In conclusion, scPLS performs better than the other methods based on multiple criteria.
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Discussion
We have presented a new method, scPLS, for removing hidden confounding factors and normalizing expression data in scRNAseq studies. scPLS uses both control and target genes to infer the confounding factors and is more effective in removing confounding effects than previous approaches that use control genes alone. With both simulations and applications to three real data sets, we have demonstrated the effectiveness of our method for controlling for hidden confounding effects in scRNAseq studies.
Although we have focused on the applications of our method to scRNAseq studies, our method can be readily applied to other genomic sequencing studies. For instance, our method can be used to remove confounding effects from gene expression levels in bulk RNAseq studies [38] or from methylation levels in bisulfite sequencing studies [39] . The main requirement of our method is a set of pre-specified control genes that are measured together with the target genes in the sequencing studies. It is often straightforward to obtain such control genes. For example, many scRNAseq studies include a set of ERCC spike-in controls that could be used to model and remove technical confounding effects [26] . Even when such ERCC spike-in controls are not present, we can select a known set of house-keeping genes as controls to remove technical confounding [25] . Similarly, we can use a set of known cell cycle genes to remove cell cycle effects. Importantly, unlike other methods, the performance of scPLS is not sensitive to the number of genes included in the control set, and yields comparable results even when a much smaller number of control genes is used (Figure 2b ). This is because scPLS not only uses information from control genes but also relies on information from target genes. Insensitivity to the control set makes scPLS especially suited to removing confounding factors in studies where a control set is not clearly defined. Because of its effectiveness and robustness, we expect scPLS to be widely useful in normalizing data from sequencing studies.
One important feature of scPLS is that it includes a low-rank component to model the structured biological variation often observed in real data. By decomposing the (residual) gene expression variation into a low-rank structured component that is likely to be contributed by a sparse set of biological factors, and an unstructured component that reflects the remaining variation, scPLS can better model the residual error structure for accurate inference of confounding effects. Although here we have focused on using the biological factors to better infer the confounding effects, we note that the low-rank biology factors themselves could be of direct interest. In fact, low-rank factors inferred from many data sets using standard factor models have been linked to important biological pathways or transcription factors [32] [33] [34] [35] [36] .
Inferring the biological factors using our current model is not feasible at the moment, however:
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The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/045070 doi: bioRxiv preprint first posted online Mar. 22, 2016; because of model identifiability, scPLS can only be used to infer the biological effects (i.e. ! ! ) but not the biological factors (i.e. ! ). That said, additional assumptions can be made on the structure of the factors or the factor loading matrices to make factor inference possible [40] . For example, we could impose sparsity assumptions on the low-rank factors to facilitate the inference of a parsimonious set of biological factors. Exploring the use of biological factors from scPLS is an interesting avenue for future research.
Like many other methods for scRNAseq [31] or bulk [41, 42] RNAseq studies, scPLS requires a data standardization step that converts the count data into quantitative expression data. Different conversion methods can affect the interpretation of the data and are advantageous in different situations [16] . Because scPLS does not rely on a particular standardization procedure, scPLS can be paired with any conversion methods to take advantage of their benefits. One important feature of scPLS is that it directly models quantitative expression data instead of raw count data. Despite the count nature of sequencing data, it has been show that there is often a limited advantage of modeling the raw read counts directly, at least for RNAseq studies [43, 44] . Statistical methods that convert and model the quantitative expression data have been shown to be robust [41, 42] and most large scale bulk RNAseq studies in recent years have used normalized data instead of count data [28, [45] [46] [47] . However, we note that, unlike bulk RNAseq studies, single cell RNAseq data often come with low read depth. In low read depth cases, modeling count data while accounting for over-dispersions (e.g. dropout events) in single cell RNAseq studies may have added benefits [17, 19] . Therefore, extending our framework to modeling count data [48, 49] is another promising avenue for future research.
CC-BY-NC-ND
Methods scRNAseq Data
We applied our method to three real data sets.
The first dataset contained both single cell sequencing data and bulk sequencing data, with a total of 251 samples cultured in two different media [18] . In particular, it included 74 mouse embryonic stem cells (mESCs) single cells cultured in a two-inhibitor (2i) medium, 45 mESCs single cells cultured in a serum medium, 56 samples with pooled RNA from mESCs cultured in a 2i medium, and 76 samples with pooled RNA from mESCs cultured in serum. The raw UMI counts (kindly provided by the authors) data contained measurements for 92 ERCC spike-ins and 23,459 genes. Due to the low coverage of this dataset (median coverage equals 1), we filtered out lowly expressed genes and selected only genes that had at least five counts in more than 1/3 of the cells. This filtering step resulted in a total of 17 ERCC spike-ins used as the controls and 2,795 genes used as the targets. Following previous approaches [4, 10, 11, 24] , we used log10 transformed values for analysis.
The second dataset contained single cell expression data from the utricular and the cochlear sensory epithelia in the inner ear of newborn mice [37] . We obtained the data from GEO website with accession number GSE71982. The original RSEM data contained count measurements for 26,585 genes of 321 cells. We removed cell types that were represented by less than five cells and focused on the resulting 307 cells from a total of six distinct cell types.
The six cell types included the hair cells (HCs), the transitional epithelial cells (TECs), and supporting cells (SCs) from each of the two tissues (utricle and cochlea). For genes, we further filtered out lowly expressed genes that had less than five counts in more than 90% of the cells and fewer variable genes that had variance less than 0.75. This yielded a set of 4,128 genes, 282 of which were annotated as cell cycle genes (see below). Among these genes, we used 3,846 non cell cycle as targets and 282 cell cycle genes as controls. Again, we used log10 transformed values for analysis. In the subset analysis, we randomly sampled 150 genes from the cell cycle genes as controls and used the rest 132 genes in the target set. We only performed four replicates in the subset analysis because results were very consistent across replicates.
The third dataset contained the transcriptional profile of 182 embryonic stem cells (ESCs) with 92 ERCC spike-ins [24] . We obtained the data from ArrayExpress database with accession number E-MTAB-2805. The cells were in three different cell-cycle phases (G1, S and G2M) which had been determined experimentally. There were 59 cells in G1 phase, 58 cells in S phase and 65 cells in G2M phase. We extracted the count data for a list of 9,571 genes as
before [24] . Among them, we focused our analysis on 629 annotated cell-cycle genes and 8,942 non cell-cycle genes with the largest variance. Again, we used log10 transformed values for analysis. For scPLS, at the first step, we used 92 spike-ins as controls and 9,571 genes as targets to remove the technical effects. The corrected data were obtained by subtracting the part contributed by the latent technical factors from the measured expression. To further remove cell cycle effects, we used 629 cell-cycle genes as controls and used 8,942 non cell cycle genes as the target set in the second step. In the subset analysis, we randomly sampled 329 genes from the controls and added the rest 300 genes to the target set. Four replicates were generated for the subset analysis.
Both the second and third dataset required a pre-specified set of cell cycle genes as controls. We used a set of 892 cell cycle genes following a previous study [24] . This set of cell cycle genes were generated by intersecting two different data sources: all cell cycle genes with GO ID 0007049 [50] , and a list of 600 top-ranked genes from CycleBase [51] .
Simulations
We simulated gene expression levels for 50 control genes and 1000 target genes for 200 cells.
These 200 cells were simulated from two equal-sized groups, representing two treatment conditions or two sub-cell types. Among the 1000 target genes, only 100 of them were differentially expressed between the two groups and thus represented the signature of the two groups. We generated the expression profile according to the following model: In scenario I, the confounding factors were independent of group effects. Here, we set ! = 6 and ! = 10 as motivated by real data analysis. We simulated each element of ! and ! from a standard normal distribution. We simulated each element of ! from (−0.2, ! ! ) and each element of from (0.2, ! ! ). Note that ! and ! were simulated differently to capture the fact that the effect sizes of the confounding factors can be different for control and target genes. We simulated each element of ! from (0, ! ! ). We simulated each element of !" and !" from a normal distribution (0, ! ! ). We simulated the 100 DE effects ! ∼ (0, ! ). We set ! ! = 1.2, ! ! = 0.4 and ! = 2.4 to ensure that, in non-DE genes, the confounding factors ! explain 10% PVE in either the control or the target genes, the biological factors ! to explain 30% PVE of the target genes, and the residual errors to explain the rest of PVE. We also set ! such that, in DE genes, the group effects explain a fixed proportion of phenotypic variance that ranging from 1% to 20% with 1% intervals. To make the simulations realistic, these PVE values were all based on real data analysis.
In scenario II, the confounding factors were correlated with group effects. The simulations here were largely similar to scenario I, with the only exception of ! . Here, each element of ! was simulated depending on the group label of i'th sample; the element of ! was simulated from (0, 1) when i'th sample belongs to group one, but was simulated from (0.5, 1)
when the sample belongs to group two. This way, ! is correlated with group label ! .
Finally, we also considered a scenario III where there were no group effects. The simulations here were largely similar to scenario I, with the only exception that all genes were non-DE, or ! = 0.
To evaluate the performance of different methods, we applied t-test to normalized data to identify DE genes. For each simulated data, we also permuted the group label 10,000 times to construct an empirical null distribution of p-values. With the empirical null, we computed power of each method for identifying DE genes based on a fixed empirical false discovery rate (FDR).
Other Methods
We compared scPLS with four other competing methods in both simulations and real data applications. The first method is PCA. We used the top k PCs from control genes as covariates to remove confounding effects from target genes. Unlike scPLS, PCA cannot infer k. Thus, we used k=k z as inferred from scPLS. The second method was LMM, implemented in the GEMMA software [52, 53] . For LMM, we used all control genes to construct a relatedness matrix. Then, we fitted a LMM for each gene in turn from the target set to remove the confounding random effects. The third method was RUV [25] . RUV is specifically designed to remove technical confounding factors. Thus, we only applied RUV to the first real data set. The fourth method between PC3 vs PC2 plot in the uncorrected data and PC2 vs PC1 plot in the scPLS corrected data. (c) Correlation of the first three PCs from either the uncorrected data (orange) or data corrected by different methods with the first PC of cell cycle genes (ccPC). Correlation is displayed on log scale. (d) Heatmap of correlations between control genes and validation genes in the subset analysis. In uncorrected data, genes from the two sets are intermingled. After scPLC correction, the two sets are easily separable. (e) In the subset analysis, pairwise correlations are computed between genes from the controls set and that from the validation set. The median correlation, as well as correlations at the up quantiles from scPLS are lower than the other methods. . Sensitivity analysis compares the estimation accuracy of scPLS with that of PCA and LMM in simulations. The three methods are applied to remove confounding effects using either 10, 30 or 50 control genes. For each gene, the estimated proportion of variance explained by the confounding effects is plotted against the truth. scPLS achieves higher correlation between the estimates and the truth. In addition, scPLS is less sensitive to the number of control genes used in the analysis. The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/045070 doi: bioRxiv preprint first posted online Mar. 22, 2016; an empirical false discovery (FDR) rate of 0.05 across 10 replicates. x--axis shows the effect sizes, which are measured as the percentage of phenotypic variation (PVE) in expression levels explained by the group label (ranges from 1% to 20%). (b) Power comparison of full model using different number of biological factors (K=2, 4, 6, 8 ) and the reduced model (K=0) when there is no biological factors in the data. Power is evaluated at an empirical false discovery (FDR) rate of 0.05 across 10 replicates. Under this setting, the full model does not perform much worse that the reduced model with respect to the power of identifying DE genes. The comparison results are also not sensitive with respect to the number of factors used in the model even when the truth is zero. Figure  S4 . The comparison of estimates of cell cycle proportion for genes in the mouse embryonic stem cell data using different scPLS algorithms: EM--in--chunks (as in the paper), naïve EM and EM--in--chunks using a subset of cell cycle genes. We only perform comparison in this data because we know the true cell cycle labels. In uncorrected data, genes from the two sets are intermingled. After scPLC correction, the two sets are easily separable. Table S1 . Comparison of the naïve EM algorithm and the EM--in--chunks algorithm in terms of accuracy and speed in simulations. The EM--in--chunks algorithm uses either a chunk size of 500 genes or a chunk size of 1,000 genes. Accuracy is measured by the estimation errors of the loading matrix in terms of the normalized Frobenius norm. Speed is measured by CPU time in seconds. n: the number of cells. p: the number of genes.
Supplementary File 1 This zip files contain gene expression levels of three described datasets before and after correcting for technical or cell cycle effect.
